Tata Consultancy Services (TCS) announced its collaboration with Dassault Systems through its Living Heart Project to drive Digital Transformation in Cardiovascular Science through Bio-Physical Simulation. To develop and validate realistic digital simulations of the human heart, the project brings together an ecosystem of cardiovascular researchers, educators, medical device developers, regulatory agencies, including the US FDA, and practising cardiologists.
According to a TCS press release, the project will create ground-breaking medical solutions, such as using heart simulation as digital evidence to approve new cardiovascular devices. The release added that the project includes in-silico clinical trials that could supplement the data obtained from clinical subjects while minimizing the demand for animal testing and human enrollment in clinical trials.
“Their deep expertise in research and technology development will bring invaluable insights to our mission and to others in the field. This collaboration demonstrates our shared commitment to leveraging the virtual world for the advancement of medical science and patient care. By joining forces, we believe we can accelerate the pace of innovation and make significant strides towards our goal of creating and delivering personalized in-silico medical solutions,” said Steve Levine, Sr. Director, Virtual Human Modeling, Dassault Systèmes and founder of The Living Heart Project.
“TCS is excited to be a part of the Living Heart initiative, and to collaborate in creating a pathbreaking digital simulation of the human heart that can enrich our understanding of the cardiac function and provide insights for novel cardiac treatments and new product development for the med-tech and pharma sectors. We believe that our extensive expertise in building digital bio-twins for other organs and body parts positions us well to contribute significantly to this collaborative initiative,” said Vikram Karakoti, Global Head of Life Sciences Business, TCS.
TCS stated that it will use its domain and technological expertise and research on the Digital BioTwin of the Heart to help with model refinement, simulation, and technological implementation when developing and validating highly accurate, personalized digital human heart models.
TCS researchers developed a biophysics-based, high-fidelity computational model called TCS Digital BioTwin to enable the study of the particular human organ’s function remotely and non-invasively.